Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
This week, Svante Pääbo, Nobel Prize winner for sequencing the Neanderthal genome, is visiting Estonia. In an interview with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback